Cargando…
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs
This cross-sectional study estimates the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063495/ https://www.ncbi.nlm.nih.gov/pubmed/32150268 http://dx.doi.org/10.1001/jamanetworkopen.2020.0423 |
| _version_ | 1783504710523682816 |
|---|---|
| author | Haslam, Alyson Gill, Jennifer Prasad, Vinay |
| author_facet | Haslam, Alyson Gill, Jennifer Prasad, Vinay |
| author_sort | Haslam, Alyson |
| collection | PubMed |
| description | This cross-sectional study estimates the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs. |
| format | Online Article Text |
| id | pubmed-7063495 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Medical Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70634952020-03-16 Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs Haslam, Alyson Gill, Jennifer Prasad, Vinay JAMA Netw Open Research Letter This cross-sectional study estimates the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs. American Medical Association 2020-03-09 /pmc/articles/PMC7063495/ /pubmed/32150268 http://dx.doi.org/10.1001/jamanetworkopen.2020.0423 Text en Copyright 2020 Haslam A et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License. |
| spellingShingle | Research Letter Haslam, Alyson Gill, Jennifer Prasad, Vinay Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs |
| title | Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs |
| title_full | Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs |
| title_fullStr | Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs |
| title_full_unstemmed | Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs |
| title_short | Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs |
| title_sort | estimation of the percentage of us patients with cancer who are eligible for immune checkpoint inhibitor drugs |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063495/ https://www.ncbi.nlm.nih.gov/pubmed/32150268 http://dx.doi.org/10.1001/jamanetworkopen.2020.0423 |
| work_keys_str_mv | AT haslamalyson estimationofthepercentageofuspatientswithcancerwhoareeligibleforimmunecheckpointinhibitordrugs AT gilljennifer estimationofthepercentageofuspatientswithcancerwhoareeligibleforimmunecheckpointinhibitordrugs AT prasadvinay estimationofthepercentageofuspatientswithcancerwhoareeligibleforimmunecheckpointinhibitordrugs |